Inventor
UHLEN MATHIAS
SE33 patents
⚠️ This page may combine multiple inventors who share the name “UHLEN MATHIAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UHLEN MATHIAS
5 patentsUS8465934B2Jun 18, 2013
Use of protein SATB2 as a marker for colorectal cancer
UHLEN MATHIAS3 citations60
US8067190B2Nov 29, 2011
Use of protein SATB2 as a marker for colorectal cancer
UHLEN MATHIAS3 citations60
US8632984B2Jan 21, 2014
RBM3 as a marker for malignant melanoma prognosis
UHLEN MATHIAS2 citations57
US8241859B2Aug 14, 2012
Use of protein SATB2 as a marker for colorectal cancer
UHLEN MATHIAS0 citations50
US8945832B2Feb 3, 2015
Treatment prediction involving HMGCR
UHLEN MATHIAS0 citations44
CEMU BIOTEKNIK AB
3 patentsUS5534424AJul 9, 1996
Chemical method for the analysis of DNA sequences
CEMU BIOTEKNIK AB179 citations98
US5405746AApr 11, 1995
Method of sequencing DNA
CEMU BIOTEKNIK AB183 citations98
US5330914AJul 19, 1994
Apparatus and method for automated purification of extra-chromo-somal DNA from a cell suspension in a container
CEMU BIOTEKNIK AB60 citations93
BIOVITRUM AB
3 patentsPF MEDICAMENT
3 patentsUS6149911ANov 21, 2000
Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
PF MEDICAMENT59 citations93
US5958736ASep 28, 1999
Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
PF MEDICAMENT32 citations89
US6558673B1May 6, 2003
Complexes of immunogens derived from RSV surface glycoprotein G covalently coupled to a support molecule
PF MEDICAMENT1 citations46
DYNAL AS
3 patentsUS6610479B1Aug 26, 2003
Activating a reversibly inactivated immobilized enzyme by release from an immobilizing moiety
DYNAL AS28 citations92
US6482592B1Nov 19, 2002
Methods and kits for isolating primer extension products using modular oligonucleotides
DYNAL AS31 citations92
US5525493AJun 11, 1996
Cloning method and kit
DYNAL AS53 citations91